In the last trading session, 1.25 million Exact Sciences Corp (NASDAQ:EXAS) shares changed hands as the company’s beta touched 1.25. With the company’s per share price at $62.08 changed hands at $0.39 or 0.63% during last session, the market valuation stood at $11.56B. EXAS’s last price was a discount, traded about -28.25% off its 52-week high of $79.62. The share price had its 52-week low at $40.62, which suggests the last value was 34.57% up since then. When we look at Exact Sciences Corp’s average trading volume, we note the 10-day average is 2.73 million shares, with the 3-month average coming to 2.70 million.
Analysts gave the Exact Sciences Corp (EXAS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.39. If we narrow down to specifics, the data shows that 0 out of 16 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 2 recommended EXAS as a Hold, 13 felt it is a Buy and 0 rated the stock as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exact Sciences Corp (NASDAQ:EXAS) trade information
Instantly EXAS was in green as seen at the end of in last trading. With action 16.98%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -16.09%, with the 5-day performance at 16.98% in the green. However, in the 30-day time frame, Exact Sciences Corp (NASDAQ:EXAS) is -11.89% down. Looking at the short shares, we see there were 13.84 million shares sold at short interest cover period of 4.59 days.
The consensus price target for the stock as assigned by Wall Street analysts is 80, meaning bulls need an upside of 22.4% from its current market value. According to analyst projections, EXAS’s forecast low is 60 with 168 as the target high. To hit the forecast high, the stock’s price needs a -170.62% plunge from its current level, while the stock would need to tank 3.35% for it to hit the projected low.
Exact Sciences Corp (EXAS) estimates and forecasts
Data shows that the Exact Sciences Corp share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 36.59% over the past 6 months, a -7.08% in annual growth rate that is considerably lower than the industry average of 17.70%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 4.59%. The 2024 estimates are for Exact Sciences Corp earnings to decrease by -7.25%.
EXAS Dividends
Exact Sciences Corp is expected to release its next quarterly earnings report in January.
Exact Sciences Corp (NASDAQ:EXAS)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.01% of Exact Sciences Corp shares while 100.83% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 101.86%. There are 100.83% institutions holding the Exact Sciences Corp stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 9.9672% of the shares, roughly 18.18 million EXAS shares worth $767.91 million.
CAPITAL WORLD INVESTORS holds the second largest percentage of outstanding shares, with 9.0493% or 16.5 million shares worth $697.18 million as of 2024-06-30.
